The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Role of aldosterone in the remnant kidney model in the rat.
Open accessAbstract
The renin-angiotensin-aldosterone system (RAAS) participates in the injury sustained by the remnant kidney. Our studies assessed the importance of aldosterone in that model and the response of aldosterone to drugs interfering with the RAAS. Initially, four groups of rats were studied: SHAM-operated rats, untreated remnant rats (REM), REM rats treated with losartan and enalapril (REM AIIA), and REM AIIA rats infused with exogenous aldosterone (REM AIIA + ALDO). The last group was maintained with aldosterone levels comparable to those in untreated REM rats by constant infusion of exogenous aldosterone. REM rats had larger adrenal glands and a > 10-fold elevation in plasma aldosterone compared to SHAM. REM AIIA rats demonstrated significant suppression of the hyperaldosteronism as well as marked attenuation of proteinuria, hypertension, and glomerulosclerosis compared to REM. REM AIIA + ALDO rats manifested greater proteinuria, hypertension, and glomerulosclerosis than REM AIIA rats. Indeed, by 4 wk of observation all of these features of the experimental disease were similar in magnitude in REM AIIA + ALDO and untreated REM. In separate REM rats spironolactone administration did not reduce glomerular sclerosis but did transiently reduce proteinuria, lowered arterial pressure, and lessened cardiac hypertrophy. In summary, aldosterone contributes to hypertension and renal injury in the remnant kidney model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Long-term control of arterial blood pressure
Cowley, A. W. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.231 · Cited by 599
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
Fournier, A., & Lalau, J. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301314 · Cited by 458
Mineralocorticoids, hypertension, and cardiac fibrosis.
Young, M., Fullerton, M., Dilley, R., & Funder, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117269 · Cited by 437
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
Lafayette, R. A., Mayer, G., Park, S. K., & Meyer, T. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115949 · Cited by 348
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
Dworkin, L. D., Hostetter, T. H., Rennke, H. G., & Brenner, B. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111349 · Cited by 282
Self-citationLarivière, R., Thibault, G., & Schiffrin, E. L. (1993) · Hypertension · doi:10.1161/01.hyp.21.3.294 · Cited by 282
Pathogenesis of the glomerulopathy associated with renal infarction in rats
Purkerson, M. L., Hoffsten, P. E., & Klahr, S. (1976) · Kidney International · doi:10.1038/ki.1976.50 · Cited by 259
Pitt, B. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877755 · Cited by 205
Plasma aldosterone concentrations in chronic renal disease
Hené, R. J., Boer, P., Koomans, H. A., & Dorhout Mees, E. J. (1982) · Kidney International · doi:10.1038/ki.1982.14 · Cited by 185
Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.
Wang, W. (1994) · Hypertension · doi:10.1161/01.hyp.24.5.571 · Cited by 161
The paradox of the renin-angiotensin system in chronic renal disease
Rosenberg, M. E., Smith, L. J., Correa‐Rotter, R., & Hostetter, T. H. (1994) · Kidney International · doi:10.1038/ki.1994.52 · Cited by 157
Self-citationAldosterone enhances angiotensin II receptor binding and inositol phosphate responses.
Ullian, M. E., Schelling, J. R., & Linas, S. L. (1992) · Hypertension · doi:10.1161/01.hyp.20.1.67 · Cited by 141
Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action
Wehling, M., Christ, M., & Theisen, K. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.5.e974 · Cited by 114
Diseases of the adrenal cortex
Kannan, C. R. (1988) · Disease-a-Month · doi:10.1016/0011-5029(88)90023-5 · Cited by 107
Role of heparin as a protective agent following reduction of renal mass
Olson, J. L. (1984) · Kidney International · doi:10.1038/ki.1984.27 · Cited by 106
Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron
Todd-Turla, K. M., Schnermann, J. B., Fejes‐Tóth, G., Náray‐Fejes‐Tóth, A., Smart, A., Killen, P. D., & Briggs, J. P. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.264.5.f781 · Cited by 105
Hypertension-Related Renal Injury: A Major Contributor to End-Stage Renal Disease
Walker, W. G. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70183-x · Cited by 104
Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway?
Wehling, M., Käsmayr, J., & Theisen, K. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e719 · Cited by 104
Adverse effects of growth in the glomerular microcirculation
Daniels, B. S., & Hostetter, T. H. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.5.f1409 · Cited by 99
Self-citationPurkerson, M. L., Tollefsen, D. M., & Klahr, S. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113312 · Cited by 86
Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys
Lax, D. S., Benstein, J. A., Tolbert, E. M., & Dworkin, L. D. (1992) · Kidney International · doi:10.1038/ki.1992.222 · Cited by 82
Wakisaka, M., Spiro, M. J., & Spiro, R. G. (1994) · Diabetes · doi:10.2337/diab.43.1.95 · Cited by 73
Quan, Z. Y., Walser, M., & Hill, G. S. (1992) · Kidney International · doi:10.1038/ki.1992.45 · Cited by 69
Animal model to study the effect of adrenal hormones on epithelial function
Martín, R. S., Jones, W., Hayslett, J. P., & Hayslett, J. P. (1983) · Kidney International · doi:10.1038/ki.1983.171 · Cited by 57
Experimental aldosterone hypertension in the dog.
Pan, Y.-J., & Young, D. B. (1982) · Hypertension · doi:10.1161/01.hyp.4.2.279 · Cited by 56
Onoyama, K., Bravo, E. L., & Tarazi, R. C. (1979) · Hypertension · doi:10.1161/01.hyp.1.3.331 · Cited by 40
Cited by
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
Aziz, F., & Chaudhary, K. (2017) · Cardiorenal Medicine · doi:10.1159/000450796 · Cited by 3,267
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,220
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease
Remuzzi, G., Perico, N., Macia, M., & Ruggenenti, P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09911.x · Cited by 505
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 496
Metadata
- Authors
- Greene, E. L., Kren, S., & Hostetter, T. H.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-08-15
- Volume
- 98
- Issue
- 4
- Pages
- 1063-1068
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2000060059
- Cited by
- 479
- References
- 30
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.